LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 113 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $56,611 | -38.4% | 51,937 | +29.5% | 0.00% | – |
| Q2 2023 | $91,868 | -7.7% | 40,117 | -2.1% | 0.00% | – |
| Q1 2023 | $99,562 | +26.5% | 40,972 | -0.6% | 0.00% | – |
| Q4 2022 | $78,736 | +5.0% | 41,223 | +31.5% | 0.00% | – |
| Q3 2022 | $75,000 | +41.5% | 31,353 | +9.9% | 0.00% | – |
| Q2 2022 | $53,000 | -14.5% | 28,523 | -4.4% | 0.00% | – |
| Q1 2022 | $62,000 | -45.1% | 29,849 | +3.7% | 0.00% | – |
| Q4 2021 | $113,000 | -15.0% | 28,778 | +3.7% | 0.00% | – |
| Q3 2021 | $133,000 | +25.5% | 27,753 | +19.7% | 0.00% | – |
| Q2 2021 | $106,000 | +45.2% | 23,185 | +85.9% | 0.00% | – |
| Q1 2021 | $73,000 | -34.8% | 12,471 | -62.0% | 0.00% | – |
| Q4 2020 | $112,000 | +239.4% | 32,824 | +39.5% | 0.00% | – |
| Q3 2020 | $33,000 | -29.8% | 23,526 | +0.4% | 0.00% | – |
| Q2 2020 | $47,000 | -75.4% | 23,435 | -31.8% | 0.00% | – |
| Q1 2019 | $191,000 | -10.7% | 34,338 | +6.4% | 0.00% | – |
| Q4 2018 | $214,000 | -48.2% | 32,261 | -16.6% | 0.00% | – |
| Q3 2018 | $413,000 | +19.7% | 38,667 | +34.3% | 0.00% | – |
| Q2 2018 | $345,000 | +189.9% | 28,782 | +107.6% | 0.00% | – |
| Q1 2018 | $119,000 | -0.8% | 13,866 | +13.8% | 0.00% | – |
| Q4 2017 | $120,000 | -18.4% | 12,181 | +1.9% | 0.00% | – |
| Q3 2017 | $147,000 | -20.5% | 11,954 | +6.2% | 0.00% | – |
| Q2 2017 | $185,000 | -97.0% | 11,260 | -97.4% | 0.00% | -100.0% |
| Q1 2017 | $6,116,000 | -13.1% | 426,534 | -16.1% | 0.00% | 0.0% |
| Q4 2016 | $7,034,000 | -36.7% | 508,590 | -17.2% | 0.00% | -50.0% |
| Q3 2016 | $11,106,000 | +25.6% | 614,606 | -0.3% | 0.00% | +33.3% |
| Q2 2016 | $8,844,000 | -3.9% | 616,278 | -20.0% | 0.00% | -25.0% |
| Q1 2016 | $9,206,000 | +429.1% | 770,370 | +489.4% | 0.00% | +300.0% |
| Q4 2015 | $1,740,000 | +23.0% | 130,709 | -0.8% | 0.00% | 0.0% |
| Q3 2015 | $1,415,000 | +28200.0% | 131,768 | +19277.6% | 0.00% | – |
| Q2 2015 | $5,000 | – | 680 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 71,178,364 | $280,443,000 | 7.61% |
| BVF INC/IL | 14,360,000 | $56,578,000 | 2.05% |
| Integral Health Asset Management, LLC | 200,000 | $788,000 | 0.22% |
| Eversept Partners, LP | 797,694 | $3,142,914 | 0.20% |
| NEA Management Company, LLC | 2,382,286 | $9,386,000 | 0.19% |
| PINNACLE ASSOCIATES LTD | 2,127,662 | $8,383,000 | 0.14% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $141,000 | 0.06% |
| Virtus ETF Advisers LLC | 41,584 | $164,000 | 0.06% |
| Pegasus Asset Management, Inc. | 10,000 | $39,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 31,562 | $124,000 | 0.02% |